In an RCT of 295 analysed adults with rectal cancer, robotic vs laparoscopic TME showed similar 5-year overall (92.4% vs 92.6%) and relapse-free survival (83.0% vs 81.9%), pre-specified secondary endpoints. Local recurrence-free survival did not differ significantly.
RCTn = 295
Song et al. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision for rectal cancer: COLRAR randomized clinical trial